Therapeutic Potentials of Human Embryonic Stem Cells in Parkinson's Disease

Neurotherapeutics

Volumn 5, Issue 2, 2008, Pages 237-251

  Newman, Mary B ^a   Bakay, Roy A E ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

central nervous system; chemokines; cytokines; growth factors; injury; microenvironment; neural stem cells; Neurotrophic; precursor cells; progenitor cells; repair; transplantation

Indexed keywords

NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

ADRENAL GLAND; ANIMAL PRODUCT; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL THERAPY; CELL TRANSPLANTATION; EMBRYONIC STEM CELL; FETUS (ANATOMY); GENETIC ANALYSIS; HUMAN; IMMUNOGENICITY; INFLAMMATION; MICROENVIRONMENT; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

CELL DIFFERENTIATION; DOPAMINE; EMBRYONIC STEM CELLS; HUMANS; PARKINSON DISEASE; STEM CELL TRANSPLANTATION;

EID: 41249094119     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2008.02.004     Document Type: Article

References (148)

1. Newman M.B., Freeman T.B., Hart C.D., and Sanberg P.R. Neural stem cells for cellular therapy in humans. In: Bottenstein J.E. (Ed). Neural stem cells: development and transplantation (2003), Kluwer Academic, New York 379-412
2. Ludwig C.L., Weinberger D.R., Bruno G., et al. Buspirone, Parkinson's disease, and the locus ceruleus. Clin Neuropharmacol 9 (1986) 373-378
3. Chan-Palay V. Depression and dementia in Parkinson's disease: catecholamine changes in the locus ceruleus, a basis for therapy. Adv Neurol 60 (1993) 438-446
4. Chan-Palay V. Locus coeruleus and norepinephrine in Parkinson's disease. Jpn J Psychiatry Neurol 45 (1991) 519-521
5. Mavridis M., Degryse A.D., Lategan A.J., Marien M.R., and Colpaert F.C. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease. Neuroscience 41 (1991) 507-523
6. Sandyk R. Hypothalamic-locus coeruleus mechanisms in the pathophysiology of "on-off" in L-dopa treated Parkinson's disease: a hypothesis. Int J Neurosci 47 (1989) 303-308
7. Gesi M., Soldani P., Giorgi F.S., Santinami A., Bonaccorsi I., and Fornai F. The role of the locus coeruleus in the development of Parkinson's disease. Neurosci Biobehav Rev 24 (2000) 655-668
8. Bertrand E., Lechowicz W., Szpak G.M., and Dymecki J. Qualitative and quantitative analysis of locus coeruleus neurons in Parkinson's disease. Folia Neuropathol 35 (1997) 80-86
9. Hoogendijk W.J., Pool C.W., Troost D., van Zwieten E., and Swaab D.F. Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis. Brain 118 (1995) 131-143
10. Zweig R.M., Cardillo J.E., Cohen M., Giere S., and Hedreen J.C. The locus ceruleus and dementia in Parkinson's disease. Neurology 43 (1993) 986-991
11. Menendez P., Bueno C., and Wang L. Human embryonic stem cells: a journey beyond cell replacement therapies. Cytotherapy 8 (2006) 530-541
12. Bankiewicz K.S., Leff S.E., Nagy D., et al. Practical aspects of the development of ex vivo and in vivo gene therapy for Parkinson's disease. Exp Neurol 144 (1997) 147-156
13. Raymon H.K., Thode S., and Gage F.H. Application of ex vivo gene therapy in the treatment of Parkinson's disease. [Erratum in: Exp Neurol 2003;25:i]. Exp Neurol 144 (1997) 82-91
14. Mogi M., and Nagatsu T. Neurotrophins and cytokines in Parkinson's disease. Adv Neurol 80 (1999) 135-139
15. Whitton P.S. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharmacol 150 (2007) 963-976
16. Collier T.J., Sortwell C.E., Elsworth J.D., et al. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease. J Comp Neurol 442 (2002) 320-330
17. Henderson J.K., Draper J.S., Baillie H.S., et al. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20 (2002) 329-337
18. Brederlau A., Correia A.S., Anisimov S.V., et al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24 (2006) 1433-1440
19. Goldman S.A., Roy N.S., Beal M.F., and Cleren C. Large stem cell grafts could lead to erroneous interpretations of behavioral results?. Nat Med 13 (2007) 118-119
20. Redmond Jr. D.E., Bjugstad K.B., Teng Y.D., et al. Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci U S A 104 (2007) 12175-12180
21. Redmond Jr. D.E., Vinuela A., Kordower J.H., and Isacson O. Influence of cell preparation and target location on the behavioral recovery after striatal transplantation of fetal dopaminergic neurons in a primate model of Parkinson's disease. Neurobiol Dis 29 (2008) 103-116
22. Freed C.R., Greene P.E., Breeze R.E., et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344 (2001) 710-719
23. Olanow C.W., and Brin M.F. Surgical therapies for Parkinson's disease: a physician's perspective. Adv Neurol 86 (2001) 421-433
24. Olanow C.W., Goetz C.G., Kordower J.H., et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann Neurol 54 (2003) 403-414
25. Kordower J.H., Goetz C.G., Freeman T.B., and Olanow C.W. Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery. Exp Neurol 144 (1997) 41-46
26. Freed C.R., Breeze R.E., and Schneck S.A. Transplantation of fetal mesencephalic tissue in Parkinson's disease. N Engl J Med 333 (1995) 730-731
27. Freeman T.B., Willing A., Zigova T., Sanberg P.R., and Hauser R.A. Neural transplantation in Parkinson's disease. Adv Neurol 86 (2001) 435-445
28. Björklund A., Dunnett S.B., Brundin P., et al. Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol 2 (2003) 437-445
29. Kordower J.H., Freeman T.B., Chen E.Y., et al. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov Disord 13 (1998) 383-393
30. Olanow C.W., Kordower J.H., and Freeman T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci 19 (1996) 102-109
31. Lajtha L.G. Bone marrow: the seedbed of blood. In: Wintrobe M.M. (Ed). Blood, pure and eloquent (1980), McGraw-Hill, New York 80-94
32. Lajtha L.G. Strategic reserves. Blood Cells 6 (1980) 381-389
33. Lajtha L.G. Haemopoietic stem cells: concept and definitions. Blood Cells 5 (1979) 447-455
34. Lajtha L.G. Stem cell concepts. Nouv Rev Fr Hematol 21 (1979) 59-65
35. Schofield R., and Lajtha L.G. Determination of the probability of self-renewal in haemopoietic stem cells: a puzzle. Blood Cells 9 (1983) 467-483
36. Rao M.S., and Mattson M.P. Stem cells and aging: expanding the possibilities. Mech Ageing Dev 122 (2001) 713-734
37. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
38. Shihabuddin L.S., Palmer T.D., and Gage F.H. The search for neural progenitor cells: prospects for the therapy of neurodegenerative disease. Mol Med Today 5 (1999) 474-480
39. Shihabuddin L.S., Ray J., and Gage F.H. Stem cell technology for basic science and clinical applications. Arch Neurol 56 (1999) 29-32
40. Rao S.G. Stem cells and their therapeutic potential. Indian J Exp Biol 39 (2001) 1205-1206
41. Seaberg R.M., and van der Kooy D. Stem and progenitor cells: the premature desertion of rigorous definitions. Trends Neurosci 26 (2003) 125-131
42. In: Marshak D.R., Gardner R.L., and Gottlieb D. (Eds). Stem cell biology (2001), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
43. Blau H.M., Brazelton T.R., and Weimann J.M. The evolving concept of a stem cell: entity or function?. Cell 105 (2001) 829-841
44. Rao M.S. Stem cells and CNS development (2001), Humana Press, Totowa, NJ
45. National Research Council (U.S.). Committee on the Biological and Biomedical Applications of Stem Cell Research.; Institute of Medicine (U.S.). Board on Neuroscience and Behavioral Health. Stem cells and the future of regenerative medicine (2002), National Academy Press, Washington, DC
46. Gage F.H. Stem cells of the central nervous system. Curr Opin Neurobiol 8 (1998) 671-676
47. Broxmeyer H.E. Primitive hematopoietic stem and progenitor cells in human umbilical cord blood: an alternative source of transplantable cells. Cancer Treat Res 84 (1996) 139-148
48. Landström U., and Løvtrup S. Fate maps and cell differentiation in the amphibian embryo: an experimental study. J Embryol Exp Morphol 54 (1979) 113-130
49. Clarke J.D., and Tickle C. Fate maps old and new. Nat Cell Biol 1 (1999) E103-E109
50. Gage P.J., Rhoades W., Prucka S.K., and Hjalt T. Fate maps of neural crest and mesoderm in the mammalian eye. Invest Ophthalmol Vis Sci 46 (2005) 4200-4208
51. Cairns J. Mutation selection and the natural history of cancer. Nature 255 (1975) 197-200
52. In: Potten C.S. (Ed). Stem cells: their identification and characterisation (1983), Churchill Livingstone, New York
53. Carpenter M.K., Rosler E., and Rao M.S. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 5 (2003) 79-88
54. Newman M.B., Davis C.D., Borlongan C.V., Emerich D., and Sanberg P.R. Transplantation of human umbilical cord blood cells in the repair of CNS diseases. Expert Opin Biol Ther 4 (2004) 121-130
55. Meyer C.H., Detta A., and Kudoh C. Hitchcock's experimental series of foetal implants for Parkinson's disease: co-grafting ventral mesencephalon and striatum. Acta Neurochir Suppl 64 (1995) 1-4
56. Hoffer B., and Olson L. Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques. J Neural Transm Suppl 49 (1997) 1-10
57. Yurek D.M., and Fletcher-Turner A. GDNF partially protects grafted fetal dopaminergic neurons against 6-hydroxydopamine neurotoxicity. Brain Res 845 (1999) 21-27
58. Mendez I., Dagher A., Hong M., et al. Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease: report of two cases and technical considerations. J Neurosurg 92 (2000) 863-869
59. Willing A.E., Othberg A.I., Saporta S., et al. Sertoli cells enhance the survival of co-transplanted dopamine neurons. Brain Res 822 (1999) 246-250
60. Imitola J., Raddassi K., Park K.I., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101 (2004) 18117-18122
61. Thored P., Arvidsson A., Cacci E., et al. Persistent production of neurons from adult brain stem cells during recovery after stroke. Stem Cells 24 (2006) 739-747
62. Ji L., Allen-Hoffmann B.L., de Pablo J.J., and Palecek S.P. Generation and differentiation of human embryonic stem cell-derived keratinocyte precursors. Tissue Eng 12 (2006) 665-679
63. Bradley J.A., Bolton E.M., and Pedersen R.A. Stem cell medicine encounters the immune system. Nat Rev Immunol 2 (2002) 859-871
64. Vanikar A.V., Mishra V.V., Firoz A., et al. Successful generation of donor specific hematopoietic stem cell lines from co-cultured bone marrow with human embryonic stem cell line: a new methodology. Transplant Proc 39 (2007) 658-661
65. Behrstock S., and Svendsen C.N. Combining growth factors, stem cells, and gene therapy for the aging brain. Ann N Y Acad Sci 1019 (2004) 5-14
66. Zhao M., Momma S., Delfani K., et al. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc Natl Acad Sci U S A 100 (2003) 7925-7930
67. Shan X., Chi L., Bishop M., et al. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice. Stem Cells 24 (2006) 1280-1287
68. Cai J., Chen J., Liu Y., et al. Assessing self-renewal and differentiation in human embryonic stem cell lines. Stem Cells 24 (2006) 516-530
69. Freed C.R. Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease?. Proc Natl Acad Sci U S A 99 (2002) 1755-1757
70. Brimble S.N., Zeng X., Weiler D.A., et al. Karyotypic stability, genotyping, differentiation, feeder-free maintenance, and gene expression sampling in three human embryonic stem cell lines derived prior to August 9, 2001. Stem Cells Dev 13 (2004) 585-597
71. Smythe G.M., and Grounds M.D. Exposure to tissue culture conditions can adversely affect myoblast behavior in vivo in whole muscle grafts: implications for myoblast transfer therapy. Cell Transplant 9 (2000) 379-393
72. Smythe G.M., Hodgetts S.I., and Grounds M.D. Immunobiology and the future of myoblast transfer therapy. Mol Ther 1 (2000) 304-313
73. Wang J.S., Shum-Tim D., Chedrawy E., and Chiu R.C. The coronary delivery of marrow stromal cells for myocardial regeneration: pathophysiologic and therapeutic implications. J Thorac Cardiovasc Surg 122 (2001) 699-705
74. Bardin N., Francès V., Lesaule G., Horschowski N., George F., and Sampol J. Identification of the S-Endo 1 endothelial-associated antigen. Biochem Biophys Res Commun 218 (1996) 210-216
75. Morrison S.J., Uchida N., and Weissman I.L. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 11 (1995) 35-71
76. Ludwig T.E., Bergendahl V., Levenstein M.E., et al. Feeder-independent culture of human embryonic stem cells. [Erratum in: Nat Methods 2006;3:867]. Nat Methods 3 (2006) 637-646
77. Ludwig T.E., Levenstein M.E., Jones J.M., et al. Derivation of human embryonic stem cells in defined conditions. Nat Biotechnol 24 (2006) 185-187
78. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. [Erratum in: Science 1998;282(5395):1827]. Science 282 (1998) 1145-1147
79. Reubinoff B.E., Pera M.F., Fong C.Y., Trounson A., and Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. [Erratum in: Nat Biotechnol 2000;18:559]. Nat Biotechnol 18 (2000) 399-404
80. Pera M.F., and Trounson A.O. Human embryonic stem cells: prospects for development. Development 131 (2004) 5515-5525
81. Pera M.F., Filipczyk A.A., Hawes S.M., and Laslett A.L. Isolation, characterization, and differentiation of human embryonic stem cells. Methods Enzymol 365 (2003) 429-446
82. Gerami-Naini B., Dovzhenko O.V., Durning M., Wegner F.H., Thomson J.A., and Golos T.G. Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology 145 (2004) 1517-1524
83. Xu R.H., Chen X., Li D.S., et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20 (2002) 1261-1264
84. Hay D.C., Sutherland L., Clark J., and Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 22 (2004) 225-235
85. Zaehres H., Lensch M.W., Daheron L., Stewart S.A., Itskovitz-Eldor J., and Daley G.Q. High-efficiency RNA interference in human embryonic stem cells. Stem Cells 23 (2005) 299-305
86. Chen H.F., Kuo H.C., Chien C.L., et al. Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Hum Reprod 22 (2007) 567-577
87. Li Y., Powell S., Brunette E., Lebkowski J., and Mandalam R. Expansion of human embryonic stem cells in defined serum-free medium devoid of animal-derived products. Biotechnol Bioeng 91 (2005) 688-698
88. Stojkovic M., Lako M., Stojkovic P., et al. Derivation of human embryonic stem cells from day-8 blastocysts recovered after three-step in vitro culture. Stem Cells 22 (2004) 790-797
89. Kannagi R., Cochran N.A., Ishigami F., et al. Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J 2 (1983) 2355-2361
90. Fenderson B.A., De Miguel M.P., Pyle A.D., and Donovan P.J. Staining embryonic stem cells using monoclonal antibodies to stage-specific embryonic antigens. Methods Mol Biol 325 (2006) 207-224
91. Ohmori K., Takada A., Yoneda T., et al. Differentiation-dependent expression of sialyl stage-specific embryonic antigen-1 and I-antigens on human lymphoid cells and its implications for carbohydrate-mediated adhesion to vascular endothelium. Blood 81 (1993) 101-111
92. Yazawa T., Ogata T., Kamma H., Shibagaki T., Iijima T., and Horiguchi H. Pulmonary blastoma with a topographic transition from blastic to more differentiated areas: an immunohistochemical assessment of its embryonic nature using stage-specific embryonic antigens. Virchows Arch A Pathol Anat Histopathol 419 (1991) 513-518
93. Draper J.S., Pigott C., Thomson J.A., and Andrews P.W. Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat 200 (2002) 249-258
94. Zhao M., Ren C., Yang H., et al. Transcriptional profiling of human embryonic stem cells and embryoid bodies identifies HESRG, a novel stem cell gene. Biochem Biophys Res Commun 362 (2007) 916-922
95. Rosler E.S., Fisk G.J., Ares X., et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 229 (2004) 259-274
96. Pruszak J., Sonntag K.C., Aung M.H., Sanchez-Pernaute R., and Isacson O. Markers and methods for cell sorting of human embryonic stem cell-derived neural cell populations. Stem Cells 25 (2007) 2257-2268
97. Fukuda H., Takahashi J., Watanabe K., et al. Fluorescence-activated cell sorting-based purification of embryonic stem cell-derived neural precursors averts tumor formation after transplantation. Stem Cells 24 (2006) 763-771
98. Marzesco A.M., Janich P., Wilsch-Brauninger M., et al. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells. J Cell Sci 118 (2005) 2849-2858
99. Fox N., Damjanov I., Martinez-Hernandez A., Knowles B.B., and Solter D. Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. Dev Biol 83 (1981) 391-398
100. + cell purification with high yield of early progenitors. J Hematother 2 (1993) 275-279
101. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci U S A 90 (1993) 8707-8711
102. Healy L., May G., Gale K., et al. The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci U S A 92 (1995) 12240-12244
103. Lu L., Xiao M., Shen R.N., Grigsby S., and Broxmeyer H.E. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 81 (1993) 41-48
104. Broxmeyer H.E., Cooper S., Hague N., et al. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice. Ann Hematol 71 (1995) 235-246
105. Broxmeyer H.E. Questions to be answered regarding umbilical cord blood hematopoietic stem and progenitor cells and their use in-transplantation. Transfusion 35 (1995) 694-702
106. Broxmeyer H.E. Cord blood as an alternative source for stem and progenitor cell transplantation. Curr Opin Pediatr 7 (1995) 47-55
107. + cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. Prog Clin Biol Res 389 (1994) 385-391
108. + cells an enhanced ex vivo expansion potential. Exp Hematol 22 (1994) 1264-1272
109. Piccirillo S.G., Reynolds B.A., Zanetti N., et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444 (2006) 761-765
110. Miraglia S., Godfrey W., Yin A.H., et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90 (1997) 5013-5021
111. Yin A.H., Miraglia S., Zanjani E.D., et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90 (1997) 5002-5112
112. Pötgens A.J., Bolte M., Huppertz B., Kaufmann P., and Frank H.G. Human trophoblast contains an intracellular protein reactive with an antibody against CD133: a novel marker for trophoblast. Placenta 22 (2001) 639-645
113. Uchida N., Buck D.W., He D., et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97 (2000) 14720-14725
114. Amit M., Shariki C., Margulets V., and Itskovitz-Eldor J. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 70 (2004) 837-845
115. Amit M., Winkler M.E., Menke S., et al. No evidence for infection of human embryonic stem cells by feeder cell-derived murine leukemia viruses. Stem Cells 23 (2005) 761-771
116. Eiges R., Schuldiner M., Drukker M., Yanuka O., Itskovitz-Eldor J., and Benvenisty N. Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Curr Biol 11 (2001) 514-518
117. Xu C., Inokuma M.S., Denham J., et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19 (2001) 971-974
118. Poltavtseva R.A., Marey M.V., Aleksandrova M.A., Revishchin A.V., Korochkin L.I., and Sukhikh G.T. Evaluation of progenitor cell cultures from human embryos for neurotransplantation. Brain Res Dev Brain Res 134 (2002) 149-154
119. Shih C.C., Weng Y., Mamelak A., LeBon T., Hu M.C., and Forman S.J. Identification of a candidate human neurohematopoietic stem-cell population. Blood 98 (2001) 2412-2422
120. Hwang W.S., Roh S.I., Lee B.C., et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. [Erratum in: Science 2005;310:1769] [Retraction in: Kennedy D. Science 2006;311:335]. Science 308 (2005) 1777-1783
121. Reubinoff B.E., Itsykson P., Turetsky T., et al. Neural progenitors from human embryonic stem cells. Nat Biotechnol 19 (2001) 1134-1140
122. Pleasure S.J., Page C., and Lee V.M. Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12 (1992) 1802-1815
123. Zhang S.C., Wernig M., Duncan I.D., Brüstle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 19 (2001) 1129-1133
124. Zhou J.M., Chu J.X., and Chen X.J. An improved protocol that induces human embryonic stem cells to differentiate into neural cells in vitro. Cell Biol Int 32 (2008) 80-85
125. Tropepe V., Hitoshi S., Sirard C., Mak T.W., Rossant J., and van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 30 (2001) 65-78
126. Gritti A., Frölichsthal-Schoeller P., Galli R., et al. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J Neurosci 19 (1999) 3287-3297
127. Eaton M.J., and Whittemore S.R. Autocrine BDNF secretion enhances the survival and serotonergic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp Neurol 140 (1996) 105-114
128. Joannides A.J., Fiore-Hériché C., Battersby A.A., et al. A scaleable and defined system for generating neural stem cells from human embryonic stem cells. Stem Cells 25 (2007) 731-737
129. Lu J., Hou R., Booth C.J., Yang S.H., and Snyder M. Defined culture conditions of human embryonic stem cells. Proc Natl Acad Sci U S A 103 (2006) 5688-5693
130. Carpenter M.K., Inokuma M.S., Denham J., et al. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol 172 (2001) 383-397
131. Kondo T., and Raff M. Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells. Science 289 (2000) 1754-1757
132. Ogawa M. Changing phenotypes of hematopoietic stem cells. Exp Hematol 30 (2002) 3-6
133. Snyder E.Y., and Macklis J.D. Multipotent neural progenitor or stem-like cells may be uniquely suited for therapy for some neurodegenerative conditions. Clin Neurosci 3 (1995) 310-316
134. Mueller F.J., Serobyan N., Schraufstatter I.U., et al. Adhesive interactions between human neural stem cells and inflamed human vascular endothelium are mediated by integrins. Stem Cells 24 (2006) 2367-2372
135. Takeuchi H., Natsume A., Wakabayashi T., et al. Intravenously transplanted human neural stem cells migrate to the injured spinal cord in adult mice in an SDF-1- and HGF-dependent manner. Neurosci Lett 426 (2007) 69-74
136. Nagatsu T., and Sawada M. Cellular and molecular mechanisms of Parkinson's disease: neurotoxins, causative genes, and inflammatory cytokines. Cell Mol Neurobiol 26 (2006) 781-802
137. Nagatsu T., Mogi M., Ichinose H., and Togari A. Cytokines in Parkinson's disease. J Neural Transm Suppl 58 (2000) 143-151
138. Nagatsu T., Mogi M., Ichinose H., and Togari A. Changes in cytokines and neurotrophins in Parkinson's disease. J Neural Transm Suppl 60 (2000) 277-290
139. Sawada M., Imamura K., and Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm Suppl 70 (2006) 373-381
140. Imamura K., Hishikawa N., Sawada M., et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol 106 (2003) 518-526
141. Drukker M., Katz G., Urbach A., et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 99 (2002) 9864-9869
142. Grinnemo K.H., Sylven C., Hovatta O., Dellgren G., and Corbascio M. Immunogenicity of human embryonic stem cells. Cell Tissue Res 331 (2008) 67-78
143. Grinnemo K.H., Kumagai-Braesch M., Mansson-Broberg A., et al. Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings. Reprod Biomed Online 13 (2006) 712-724
144. Drukker M., Katchman H., Katz G., et al. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 24 (2006) 221-229
145. Li L., Baroja M.L., Majumdar A., et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22 (2004) 448-456
146. Bakay R.A., Boyer K.L., Freed C.R., and Ansari A.A. Immunological responses to injury and grafting in the central nervous system of nonhuman primates. Cell Transplant 7 (1998) 109-120
147. Rao B.M., and Zandstra P.W. Culture development for human embryonic stem cell propagation: molecular aspects and challenges. Curr Opin Biotechnol 16 (2005) 568-576
148. Ponsaerts P., van Tendeloo V.F., Jorens P.G., Berneman Z.N., and van Bockstaele D.R. Current challenges in human embryonic stem cell research: directed differentiation and transplantation tolerance. J Biol Regul Homeost Agents 18 (2004) 347-351